8-K: Butterfly Network Reports Strong Q3 Growth, Raises Full Year Guidance

Butterfly Network announced a 33% year-over-year revenue increase in Q3 2024, alongside improved full-year revenue and adjusted EBITDA guidance.

Summary

• Butterfly Network reported a 33% year-over-year revenue growth in the third quarter of 2024, reaching $20.6 million.
• The company reduced its net loss by 38% and net cash used in operations by 50% compared to the same period last year.
• Product revenue increased by 55% year-over-year, driven by a 37% increase in units fulfilled and higher selling prices of the iQ3.
• Software and other services revenue grew by 5% year-over-year, representing 34% of total revenue.
• Butterfly Network has raised its full-year revenue guidance to $79 million to $81 million, indicating over 20% growth.
• The company also improved its adjusted EBITDA guidance by $5 million, projecting a loss of $42 million to $40 million for the full year.
• The company launched the iQ3 in Europe and expanded into new markets including Indonesia, the Netherlands, and Belgium.
• Butterfly Network announced the formation of Octiv, a wholly-owned subsidiary focused on leveraging its chip technology in new sectors.

Sentiment

Score: 8

Explanation: The document presents a positive outlook with strong revenue growth, reduced losses, and improved guidance. The formation of a new subsidiary and expansion into new markets are also positive indicators. However, the company is still operating at a loss and faces risks, which prevents a perfect score.

Positives

• The company achieved a 33% year-over-year revenue growth in Q3 2024.
• Net loss was reduced by 38% compared to the same quarter last year.
• Net cash used in operations decreased by 50% year-over-year.
• Product revenue increased by 55% year-over-year.
• Full-year revenue guidance was raised to $79 million to $81 million.
• Adjusted EBITDA guidance was improved by $5 million.
• The company successfully launched iQ3 in Europe and expanded into new international markets.
• The formation of Octiv is expected to unlock value for current shareholders and attract new investors.
• The company is seeing positive results from its medical education and veterinary advancements.
• Butterfly HomeCare is set to begin a pilot for virtual chronic care management.

Negatives

• Gross margin decreased to 59.5% from 60.8% in the prior year period due to higher manufacturing costs of iQ3 and product mix.
• Software and other services mix decreased by 9 percentage points versus the prior year due to the higher product revenue achieved this quarter.
• The company is still operating at a loss, with a net loss of $16.9 million for the quarter.
• Adjusted EBITDA is still negative, with a loss of $8.4 million for the quarter.

Risks

• The company's ability to regain compliance with the continued listing standards of the NYSE is a risk.
• The company's ability to continue to comply with applicable listing standards of the NYSE is a risk.
• The company's future performance is subject to various risks and uncertainties, including market acceptance of its products and services.
• The company's ability to manage growth effectively is a risk.
• The company's ability to obtain and maintain regulatory approval for its products is a risk.
• The company's ability to compete with other companies is a risk.
• The company's ability to raise financing in the future is a risk.

Future Outlook

Butterfly Network has increased its full-year revenue guidance to $79 million to $81 million, representing over 20% growth, and improved its adjusted EBITDA guidance to a loss of $40 million to $42 million.

Management Comments

• Joseph DeVivo, Butterfly's President, Chief Executive Officer and Chairman, stated that the company is proud to report a fifth consecutive quarter in which they met or exceeded expectations.
• DeVivo noted that the third quarter delivered growth of 33% versus 2023, while reducing cash use to a historic low.
• DeVivo mentioned that the company remains fully committed to the strategic growth pillars introduced at their March 2024 Investor Day.
• DeVivo stated that the company is pleased to be giving improved guidance on the top and bottom line.

Industry Context

This announcement highlights Butterfly Network's continued growth in the digital health and medical imaging sector, particularly with its innovative handheld ultrasound technology. The expansion into new markets and the formation of Octiv demonstrate the company's strategic focus on leveraging its technology across various sectors.

Comparison to Industry Standards

• Butterfly Network's 33% year-over-year revenue growth in Q3 is strong compared to some established medical device companies, but it is important to note that Butterfly is still in a growth phase and not yet profitable.
• Comparable companies in the medical imaging space include GE Healthcare, Philips, and Siemens Healthineers, which typically have more stable but lower growth rates.
• The launch of iQ3 and expansion into new markets is similar to strategies employed by other medical device companies to drive growth.
• The formation of Octiv to explore new applications of their chip technology is a unique approach that could differentiate Butterfly from its competitors.
• The focus on medical education and veterinary applications is also a strategic move to expand the market for their technology.

Stakeholder Impact

• Shareholders are likely to react positively to the strong revenue growth and improved guidance.
• Employees may be encouraged by the company's positive performance and future prospects.
• Customers will benefit from the continued innovation and expansion of Butterfly's products and services.
• Suppliers may see increased demand for their products and services.
• Creditors may view the company's improved financial performance favorably.

Next Steps

• Butterfly HomeCare is set to begin a pilot for virtual chronic care management in Q4 2024.
• The company will continue to develop and expand the applications of its chip technology through Octiv.
• The company will continue to focus on its strategic growth pillars introduced at the March 2024 Investor Day.

Key Dates

Keywords

ultrasound, medical imaging, digital health, semiconductor, Butterfly Network, iQ3, Octiv, revenue growth, EBITDA, financial results